“Conjunctivitis Does Not Increase With Longer Duration of Lebrikizumab Exposure in Patients With Moderate-to-Severe Atopic Dermatitis”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s276. https://doi.org/10.25251/skin.7.supp.276.